NCT02986308

Brief Summary

The aim of this study is to confirm the TCM syndrome types and TCM constitution classifications of the patients with intestinal polyps via on-site epidemiological survey, to analyze metabolomics of the serum samples of intestinal polyps and healthy volunteers, and to study the metabolomics differences of the two populations and the metabolomics variations of the patients with intestinal polyps of pre-polypectomy and post-polypectomy. Finally, this study is to investigate the serum metabolomics variations of patients with intestinal polyps of pre-polypectomy and post-polypectomy and the relationship with their TCM syndrome types and TCM constitution classifications, to determine the correlation among pathology, TCM constitution, TCM syndrome types and the metabonomics variations of patients with intestinal polyps.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,659

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2016

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 8, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2019

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2019

Completed
Last Updated

February 18, 2020

Status Verified

February 1, 2020

Enrollment Period

2.6 years

First QC Date

August 1, 2016

Last Update Submit

February 16, 2020

Conditions

Keywords

MetabolomicsIntestinal PolypsTCM SyndromesTCM Constitution Types

Outcome Measures

Primary Outcomes (1)

  • Aiming to obtain biomarker groups of different pathological types of intestinal polyps, The potential biomarkers will be entered KEGG database to obtain metabolic pathways.

    2 years

Secondary Outcomes (1)

  • All data matrices are introduced to Ezinfo software for PCA and OPLS-DA. Using improved "MetPA enriched pathways" method to discover the metabolic pathways of the disease.

    3 days

Study Arms (2)

Intestinal Polyps

The patients who were diagnosed with Intestinal Polyps.

Other: No intervention

Normal colonoscopy

People who were diagnosed by colonoscopy without intestinal polyps.

Other: No intervention

Interventions

Intestinal PolypsNormal colonoscopy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Intestinal polyps patients

You may qualify if:

  • Age 20 to 80,all genders;
  • Intestinal polyps were found by colonoscopy;
  • The patients are scheduled for polypectomy;
  • Preoperative examinations were completed;
  • Performance status 0-1;
  • Diet has well controlled prior to the operation;
  • Patients or their statutory agent have signed the informed consent forms.

You may not qualify if:

  • The patient has not diagnosed by colonoscopy;
  • The patient has surgical contraindication;
  • Patients in pregnant or lactational period ;
  • Psychopath;
  • The patient is in drug trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, 150001, China

Location

Related Publications (1)

  • Du WZ, Zhang AH, Ren JL, Lyu K, Tuo LY, Xu W. Study of Differential Serum Metabolites in Patients with Adenomatous Polyps of Colon and Yang-Deficiency Constitution Based on Ultra-Performance Liquid Chromatography-Mass Spectrometry. Chin J Integr Med. 2022 May;28(5):403-409. doi: 10.1007/s11655-019-3181-9. Epub 2019 Nov 29.

Biospecimen

Retention: SAMPLES WITH DNA

serum

MeSH Terms

Conditions

Intestinal Polyps

Condition Hierarchy (Ancestors)

PolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Wei Xu, Doctor

    First Affiliated Hospital of Harbin Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
10 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,Professor

Study Record Dates

First Submitted

August 1, 2016

First Posted

December 8, 2016

Study Start

June 13, 2016

Primary Completion

January 21, 2019

Study Completion

February 19, 2019

Last Updated

February 18, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations